Response – Building on existing knowledge and redefining rather than abandoning the well‐established ‘clinical high risk for psychosis’ prevention paradigm
Gonzalo Salazar de Pablo, Claudia Aymerich, Grace Frearson, Javier de Otazu Olivares, Ana Catalan

TL;DR
The paper argues for refining the clinical high risk for psychosis prevention model instead of abandoning it, emphasizing its importance in mental health.
Contribution
The paper proposes integrating precision medicine and transdiagnostic interventions to improve and expand the existing clinical high risk for psychosis paradigm.
Findings
The clinical high risk for psychosis paradigm is widely implemented and provides evidence-based interventions.
Negative symptoms in adolescents at clinical high risk for psychosis significantly impact functioning and outcomes.
Advancements in precision medicine can enhance risk stratification and intervention tailoring.
Abstract
We appreciate the commentary by Tiffin and Kelleher on our systematic review and meta‐analysis. The CHR‐P paradigm remains one of the most established preventive approaches in mental health. While concerns have been raised regarding the clinical utility of the CHR‐P paradigm, its implementation in specialized services worldwide supports its relevance. These services provide evidence‐based interventions, reducing unnecessary antipsychotic use and guiding treatment strategies. Tiffin and Kelleher's critique largely focuses on transition rates and age cutoffs. While we argue that transition rates in adolescents at CHR‐P are significant, other outcomes need to be considered. Among others, negative symptoms are clinically significant in adolescents at CHR‐P, impairing functioning and long‐term outcomes. We think we should refine and improve the CHR‐P paradigm rather than simply abandoning…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsSchizophrenia research and treatment · Bipolar Disorder and Treatment · Child and Adolescent Psychosocial and Emotional Development
